KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,294 | -15.9% | 9,062 | +7.9% | 0.01% | -13.3% |
| Q2 2023 | $1,821,106 | +25.9% | 8,398 | +5.4% | 0.02% | +15.4% |
| Q1 2023 | $1,446,763 | -2.5% | 7,965 | +5.5% | 0.01% | -7.1% |
| Q4 2022 | $1,483,379 | -9.1% | 7,549 | +4.1% | 0.01% | -17.6% |
| Q3 2022 | $1,632,000 | +112.8% | 7,255 | +19.7% | 0.02% | +142.9% |
| Q2 2022 | $767,000 | +7.9% | 6,059 | +8.1% | 0.01% | +16.7% |
| Q1 2022 | $711,000 | -2.5% | 5,605 | +0.7% | 0.01% | 0.0% |
| Q4 2021 | $729,000 | +6.1% | 5,568 | -0.9% | 0.01% | 0.0% |
| Q3 2021 | $687,000 | +17.2% | 5,617 | +9.3% | 0.01% | +20.0% |
| Q2 2021 | $586,000 | +38.9% | 5,141 | +46.4% | 0.01% | +25.0% |
| Q1 2021 | $422,000 | +19.5% | 3,512 | +1.1% | 0.00% | +33.3% |
| Q4 2020 | $353,000 | +28.8% | 3,473 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $274,000 | -7.1% | 3,548 | +33.9% | 0.00% | -25.0% |
| Q2 2020 | $295,000 | – | 2,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |